Reviewed by Thomas Okafor, Peptide Chemist · Updated October 2026

Matrixyl is the trade name for palmitoyl pentapeptide-4, a five-amino-acid piece of collagen with a fatty-acid tail attached so it can soak into skin. It’s one of the most widely used peptides in anti-aging creams and serums, studied for whether it nudges skin cells to make more collagen and smooth fine lines.

Matrixyl is a cosmetic ingredient made by the French company Sederma, now part of Croda. Its human evidence comes from a handful of small cream and serum trials, several run by skincare companies, plus lab work on skin cells. It’s never been tested or approved as a drug, and it’s sold in finished skincare products and as a research-grade powder.

Matrixyl isn’t approved as a drug for any use, and research-grade Matrixyl is sold for research use only. This guide is educational; see our Medical Disclaimer.

What Is Matrixyl?

Matrixyl is a cosmetic peptide ingredient: the sequence lysine-threonine-threonine-lysine-serine (KTTKS) with palmitic acid, a common skin-friendly fat, attached to one end. Sederma introduced it around 2000 for anti-wrinkle products, and it now appears in drugstore and department-store creams across the US.

Where the sequence came from. In 1993, researchers at the University of Tennessee in Memphis were studying the leftover pieces that get trimmed off collagen as it’s built. They found that a tiny five-amino-acid stretch of one of these pieces, KTTKS, was the minimum sequence needed to boost collagen and fibronectin production in lab-grown cells. That finding became the scientific basis for Matrixyl.

Why the fat tail. Plain KTTKS is water-loving and has trouble crossing the skin’s oily outer barrier. Adding palmitic acid (the “palmitoyl” in its name) makes it more fat-friendly, a common trick in cosmetic chemistry. The result is a molecule of about 802 daltons, small enough to work into the outer skin layers.

How it caught on. Procter & Gamble published a placebo-controlled face trial in 2005 and used peptides in its Olay line. In the UK, a University of Manchester study of a peptide-containing drugstore serum drew wide press coverage. Since then, “peptide serum” has become a standard skincare shelf category.

Also known as: pal-KTTKS, Matrixyl 3000 and synthe’6

Palmitoyl pentapeptide-4 is the official cosmetic ingredient (INCI) name; older labels say palmitoyl pentapeptide-3. Pal-KTTKS describes the chemistry. Watch out for the brand family: Matrixyl 3000 is a different blend of two peptides (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7), and Matrixyl synthe’6 is palmitoyl tripeptide-38. Each has its own data, so results for one don’t carry over to the others.

How Does Matrixyl Work?

Matrixyl is thought to work as a matrikine: a fragment of broken-down skin matrix that signals fibroblasts, the skin’s collagen-making cells, to rebuild. In lab studies, KTTKS and pal-KTTKS raised production of collagen and other matrix proteins. How much reaches those cells in living human skin is still an open question.

What’s known, and from what kind of research:

  • Collagen signaling (lab): KTTKS boosted type I and III collagen and fibronectin in cultured fibroblasts in the 1993 Tennessee study, and later lab work with pal-KTTKS found similar effects.
  • Skin entry (animal): in a 2014 study of mouse skin, pal-KTTKS turned up in all skin layers, mostly in the outermost layer, while plain KTTKS wasn’t detected at all. Neither passed all the way through.
  • Skin entry (human): a 2026 study in three women found both Matrixyl 3000 peptides throughout the outer skin barrier, lodged between cells.
  • Breakdown (animal): skin enzymes broke down both forms quickly in the mouse study, with the palmitoyl version lasting longer.
  • Fibrillin repair (human): a multi-ingredient serum containing a lipopentapeptide increased fibrillin-1, an elastic-fiber protein lost in sun-damaged skin, in biopsies.

What does Matrixyl do? Picture a home after a remodel, with scraps of old drywall left on the floor. A contractor who sees the scraps knows repairs are needed and orders more material. Matrixyl mimics one of those scraps, hoping to trick skin cells into “ordering” more collagen. The open question is how many of those scraps reach the crew in the deeper skin.

What Is Matrixyl Used For / Studied For?

Matrixyl has been studied mainly for fine lines and wrinkles on the face and around the eyes, and for sun-damaged (photoaged) skin. Smaller lines of work look at wound dressings in animals and skin during radiation therapy. All human studies used creams or serums applied to the skin.

Wrinkles and fine lines

What was studied: a 12-week half-face trial in 93 women aged 35 to 55 comparing a moisturizer with and without pal-KTTKS, and a 2023 trial in 21 Indonesian women comparing palmitoyl pentapeptide-4 cream, an acetyl hexapeptide-3 cream and placebo for crow’s feet.

What it found: in the 2005 trial, the peptide side showed fewer visible wrinkles and fine lines than the plain moisturizer, measured by image analysis and expert graders, and it was well tolerated. In the 2023 trial, the Matrixyl cream appeared to do best of the three.

What it doesn’t show: independent replication at scale. The 2005 trial was run by Procter & Gamble scientists and included only white women; the 2023 trial had about seven people per group.

Sun-damaged skin

What was studied: a 2009 University of Manchester trial of 60 people with photoaged skin, using a commercial serum (with a lipopentapeptide plus other actives) or its base for six months, followed by six months where everyone used the serum.

What it found: at six months, 43% of serum users had better facial wrinkles compared with 22% on the base, but that difference between groups wasn’t statistically clear (p = 0.10). After 12 months, the serum beat the projected base result (70% vs 33% improving). Biopsies showed more fibrillin-1.

What it doesn’t show: which ingredient did the work, since the serum contained several actives.

Skin during radiation therapy

What was studied: a 2004 German trial of 20 women with breast cancer, comparing a cream containing Matrixyl and two other actives with standard lotion during radiotherapy.

What it found: no difference in skin reactions between the two creams. Mild itchiness was more common with the Matrixyl-containing cream.

What it doesn’t show: any protective benefit against radiation skin damage.

What Matrixyl hasn’t been shown to do

It hasn’t been shown to match prescription retinoids, fill deep wrinkles, firm sagging skin, regrow lashes or heal wounds in people. Matrixyl injections and microneedling with it haven’t been tested in published human trials.

What Does the Human Research Show?

Matrixyl’s human research is a set of small topical trials, from 20 to 93 people and four weeks to a year. Results lean favorable for fine lines, but several studies tested multi-ingredient products or were run by companies selling peptide skincare, and none has been large enough to settle the question.

Study Year Design Participants Result Limitation
Röper et al. 2004 Randomized vs standard lotion 20 women in radiotherapy No difference; more itch Multi-ingredient; small
Robinson et al. 2005 Double-blind, half-face, 12 weeks 93 women, 35–55 Fewer wrinkles and fine lines vs moisturizer Company-run; one skin type
Kaczvinsky et al. 2009 Two half-face RCTs, 4 weeks 42 and 35 women Smoother crow’s feet vs no treatment Multi-ingredient; company-run
Watson et al. 2009 Double-blind RCT, then open phase 60 adults, photoaged 43% vs 22% improved; group gap p = 0.10 Multi-ingredient serum
Aruan et al. 2023 Double-blind RCT, 8 weeks 21 women Best of three creams for crow’s feet About 7 per group

PubMed (64 records for Matrixyl peptide names) and ClinicalTrials.gov (no registered Matrixyl trials) searched October 5, 2026.

That’s thinner than it sounds for an ingredient on so many shelves, and it’s typical of cosmetics, which don’t need clinical trials to be sold. Our Editorial Policy explains how we rate company-funded studies.

Matrixyl Side Effects and Safety

Matrixyl has been well tolerated in topical studies, with mild irritation the main issue. Because so little of it reaches the deeper skin and it breaks down quickly, body-wide effects aren’t expected from creams. The bigger unknowns are for uses that have never been tested, such as injecting it.

Reported in human studies: the 2005 trial described pal-KTTKS as well tolerated. In the radiotherapy trial, mild itchiness and occasional small bumps were more common with the Matrixyl-containing cream.

Expected from the mechanism: as with any skincare ingredient, redness, stinging or contact allergy are possible, especially on broken or sensitive skin. Peptide breakdown products are ordinary amino acids and palmitic acid.

Anecdotal only: online reviewers sometimes describe “purging” or breakouts after starting peptide serums. These reports usually involve products with many ingredients and haven’t been studied.

Product quality: finished cosmetics usually list Matrixyl by its INCI name without saying how much is in the bottle. Research-grade powders are a separate category; our peptide COA guide explains how identity and purity testing work.

Who should avoid Matrixyl

People with a known allergy to a peptide skincare product, or with eczema flares or broken skin in the area, have the clearest reason to skip it. Anyone pregnant may want to check ingredients with a clinician, though no specific risk has been reported.

Is it safe to inject Matrixyl?

There’s no published human research on injecting Matrixyl, and it was designed and tested only for use on the skin’s surface. Ads for “Matrixyl injections” or “peptide injections” go well beyond what the evidence covers.

Matrixyl vs GHK-Cu

Matrixyl and GHK-Cu are both matrikine-style skin peptides, and both appear in anti-aging products. GHK-Cu carries copper and has broader lab data on wound repair and gene activity. A neat link: Matrixyl 3000 contains palmitoyl tripeptide-1, which is GHK without the copper.

Matrixyl GHK-Cu
Mechanism Collagen-fragment signal (KTTKS) Copper-carrying signal; collagen, repair genes
Half-life Breaks down quickly in skin Short in blood; topical data mostly
Evidence Small topical trials Small topical trials plus wider lab work
Status Cosmetic ingredient Cosmetic ingredient; injectable form not approved

Our full comparison, GHK-Cu vs Matrixyl, covers the trials side by side, and the GHK-Cu guide goes deeper on the copper peptide.

Matrixyl is legal to sell in the US as a cosmetic ingredient, the same category as moisturizers and lipstick. It isn’t an FDA-approved drug, and creams containing it can’t legally claim to treat a disease or change the body’s structure. Research-grade powder is sold separately under a “research use only” label.

FDA and cosmetics. Cosmetics don’t need FDA approval before sale. Under the Modernization of Cosmetics Regulation Act of 2022, companies must register facilities, list products, keep safety evidence and report serious adverse events. The FDA has warned skincare companies that claims about boosting collagen or “repairing” skin can turn a cream into an unapproved drug, which is why labels say things like “visibly reduces the look of fine lines.”

Compounding. Matrixyl hasn’t been nominated for the FDA’s 503A compounding lists, and it isn’t used in prescription products.

Research use only. Powders sold for research aren’t cosmetics or drugs, and that label means no one has checked them for human use. Our guide to whether research peptides are legal explains the difference.

Sport. Matrixyl isn’t named on the 2026 WADA Prohibited List, and as a topical cosmetic ingredient it’s not a performance concern.

FDA and WADA status checked October 5, 2026.

Where Matrixyl Fits: Needs & Symptoms

Matrixyl appears in Skin Health & Regeneration, described as a cosmetic-research peptide studied for stimulating collagen synthesis at the dermal level. It’s the only compound on that page whose research is almost entirely in finished skincare products.

The other guides on that page come at skin from different directions: GHK-Cu through copper signaling, thymosin beta-4 through wound and eye trials, and melanotan II through pigment, with a long safety record to read first.

Frequently Asked Questions

What does Matrixyl do to your skin?

In lab studies it signals skin cells to make more collagen. In small topical trials, creams with it reduced the look of fine lines and wrinkles over 8 to 12 weeks.

Is Matrixyl the same as Matrixyl 3000?

No. Matrixyl is palmitoyl pentapeptide-4. Matrixyl 3000 is a blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7, with its own separate data.

Is retinol better than Matrixyl?

Retinoids have far more research, and prescription tretinoin is FDA-approved for sun-damaged skin. Matrixyl has fewer, smaller trials. No large study has compared the two head to head.

How long does Matrixyl take to show results?

In published trials, changes were measured at 4 to 12 weeks, and the Manchester study tracked people for a full year. Results were modest and measured by imaging and graders.

What should you not use with Matrixyl?

No published studies have tested Matrixyl combinations. Cosmetic chemists often keep peptides separate from very acidic exfoliants, which may break them down, but that hasn’t been tested in trials.

Is Matrixyl safe?

In topical studies, it’s been well tolerated, with mild itch or irritation the main reports. Injected or microneedled use hasn’t been studied.

Does Matrixyl actually reach the deeper skin?

Partly. Mouse-skin and human studies found it throughout the outer layers, with only small amounts deeper. How much reaches collagen-making cells in human skin isn’t known.

Is Matrixyl a drug?

No. It’s a cosmetic ingredient. Products with it can claim to improve how skin looks, but not to treat a condition or change skin structure.

How much Matrixyl should be used?

There’s no research-based dosing for non-approved use, and we don’t publish dosing for any compound. See our Medical Disclaimer.

Sources

Primary studies

  1. Katayama K, et al. 1993. A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry. PMID 8486721
  2. Röper B, et al. 2004. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. Strahlentherapie und Onkologie. doi:10.1007/s00066-004-1174-9
  3. Robinson LR, et al. 2005. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science. doi:10.1111/j.1467-2494.2005.00261.x
  4. Kaczvinsky JR, et al. 2009. Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. Journal of Cosmetic Dermatology. doi:10.1111/j.1473-2165.2009.00444.x
  5. Watson REB, et al. 2009. A cosmetic ‘anti-ageing’ product improves photoaged skin: a double-blind, randomized controlled trial. British Journal of Dermatology. doi:10.1111/j.1365-2133.2009.09216.x
  6. Choi YL, et al. 2014. Dermal stability and in vitro skin permeation of collagen pentapeptides (KTTKS and palmitoyl-KTTKS). Biomolecules & Therapeutics. doi:10.4062/biomolther.2014.053
  7. Aruan RR, et al. 2023. Double-blind, randomized trial on the effectiveness of acetylhexapeptide-3 cream and palmitoyl pentapeptide-4 cream for crow’s feet. Journal of Clinical and Aesthetic Dermatology. PMID 36909866
  8. Trzaska AH, et al. 2026. Permeation behaviour of cosmetic actives into the human stratum corneum. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2026.127447

Regulatory

Disclaimer: Matrixyl isn’t approved as a drug for any use, and research-grade Matrixyl is sold for research use only. This guide is educational and doesn’t give medical advice. Read our Medical Disclaimer and Editorial Policy.